Endothelial Protein C Receptor and Its Impact on Rheumatic Disease
Endothelial Protein C Receptor (EPCR) is a key regulator of the activated protein C anti-coagulation pathway due to its role in the binding and activation of this protein. EPCR also binds to other ligands such as Factor VII and X, γδ T-cells, plasmodium falciparum erythrocyte membrane protein 1, and...
Main Authors: | Zachary Daniel O’Hehir, Tom Lynch, Sean O’Neill, Lyn March, Meilang Xue |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/13/7/2030 |
Similar Items
-
Possible Role of Anti-Cyclic Citrullinated Peptide Antibody (Anti-CCP Ab) in Rheumatic Diseases
by: Eman Sh Al-Obeidy, et al.
Published: (2019-11-01) -
Possible Role of Anti-Cyclic Citrullinated Peptide Antibody (Anti-CCP Ab) in Rheumatic Diseases
by: Eman Sh Al-Obeidy, et al.
Published: (2019-11-01) -
Comparative characteristics of the level of highly sensitive C-reactive protein in patients with systemic lupus erythematosus and rheumatoid arthritis
by: Yu. R. Akhverdyan, et al.
Published: (2021-08-01) -
Metabolic Syndrome in Rheumatic Diseases:
A Review Article
by: Maryam Mobini
Published: (2021-02-01) -
Diagnostic Power of Galectin-3 in Rheumatic Diseases
by: Ewa Gruszewska, et al.
Published: (2020-10-01)